Healio4d
Decline in lower extremity trauma reimbursement may pose threat to health care access
Inflation-adjusted reimbursement rates for lower extremity trauma procedures have significantly decreased since 2006. Meanwhile, health care expenditure and inflation are increasing. SAN DIEGO ...
Physician's Weekly5d
Evaluating ChatGPT-4 in Assessing Limb Salvage Versus Amputation
The following is a summary of "Management of Lower Extremity Traumas: Comparing Appropriate Use Criteria with ChatGPT ...
Humacyte Stock (HUMA) Hits Record Low Post Q4 Results Despite FDA Nod for Vascular Trauma Treatment
Biotechnology firm Humacyte’s (HUMA) shares have declined since the company presented its fourth-quarter and full-year 2024 ...
Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update
Received U.S. Food and Drug Administration (FDA) approval of Symvess™ (acellular tissue engineered vessel-tyod) for the treatment of extremity ...